Individuals Coming Off Anti-Obesity Jabs Regain Pounds Four Times Faster Compared to Dieters

Fresh analysis reveals that people who stop using popular weight-loss injections like Mounjaro or Wegovy tend to recover shed pounds far faster than those who stop conventional lifestyle plans.

Findings released in a leading health publication shows that while obese individuals frequently drop substantial amounts of their body weight while undergoing treatment, the weight is regained at an average rate of nearly a kilo each month upon discontinuation.

"Individuals using such medications need to be cognizant of the danger of fast weight regain when the treatment concludes," stated researcher Dr. Susan Jebb.

Such speed of regain means a return to original mass in about a year and a half.

Analyzing Therapies

The study, which looked at 37 of trials involving thousands of participants, compared the effects of these new drugs with older methods.

The team note that people who lose weight through lifestyle changes alone generally see a more gradual creep back—around 100 grams monthly—once they finish.

Explaining the Quick Rebound

Doctors believe the way of the jabs explains the heightened regain.

GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.

"Artificially providing GLP-1 levels far above than normal could lead to the body to produce less of its own natural hormone, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a nutrition researcher.

"Stopping of this GLP-1 'fix' means hunger is no longer kept in check, making binge eating much more probable."

A Lifelong Issue?

Medical guidelines recommend the jabs for people with weight-linked health risks, alongside prescribed lifestyle changes.

A number of clinicians say that, given the likelihood of weight regain, the treatment should be considered life-long.

This view is echoed by drug manufacturers, who note that the results "emphasize the persistent nature of excess weight," comparing it to managing diseases like diabetes.

User Experiences

Users who have come off the jabs report a intense resurgence of hunger.

"It felt as if something flipping and you become ravenous," described an individual.

This challenge is exacerbated if individuals have not established permanent lifestyle or habit changes during treatment.

Growing Interest

Survey data indicate that millions of adults in the UK have used these injections in the last 12 months, with demand remaining high.

• Use is higher among women than men.
• The middle-aged age group shows the highest level of interest.
• Many access the medications through private healthcare rather than the NHS.

In conclusion, clinicians caution that while the jabs are potent tools for weight loss, they are not a magic fix and long-term success likely depends on ongoing lifestyle management.